BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 17976098)

  • 1. Cardiac resynchronization therapy: gender related differences in left ventricular reverse remodeling.
    Lilli A; Ricciardi G; Porciani MC; Perini AP; Pieragnoli P; Musilli N; Colella A; Del Pace S; Michelucci A; Turreni F; Sassara M; Achilli A; Barold SS; Padeletti L
    Pacing Clin Electrophysiol; 2007 Nov; 30(11):1349-55. PubMed ID: 17976098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term survival in patients treated with cardiac resynchronization therapy: a 3-year follow-up study from the InSync/InSync ICD Italian Registry.
    Gasparini M; Lunati M; Santini M; Tritto M; Curnis A; Bocchiardo M; Vincenti A; Pistis G; Valsecchi S; Denaro A;
    Pacing Clin Electrophysiol; 2006 Dec; 29 Suppl 2():S2-10. PubMed ID: 17169128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of long-term resynchronization therapy on left ventricular remodeling in pacemaker patients upgraded to biventricular devices.
    Vatankulu MA; Goktekin O; Kaya MG; Ayhan S; Kucukdurmaz Z; Sutton R; Henein M
    Am J Cardiol; 2009 May; 103(9):1280-4. PubMed ID: 19406272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial.
    Daubert C; Gold MR; Abraham WT; Ghio S; Hassager C; Goode G; Szili-Török T; Linde C;
    J Am Coll Cardiol; 2009 Nov; 54(20):1837-46. PubMed ID: 19800193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of cardiac resynchronization therapy in very old patients: the Insync/Insync ICD Italian Registry.
    Achilli A; Turreni F; Gasparini M; Lunati M; Sassara M; Santini M; Landolina M; Padeletti L; Puglisi A; Bocchiardo M; Orazi S; Perego GB; Valsecchi S; Denaro A
    Europace; 2007 Sep; 9(9):732-8. PubMed ID: 17636304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term clinical outcome and left ventricular lead position in cardiac resynchronization therapy.
    Kronborg MB; Albertsen AE; Nielsen JC; Mortensen PT
    Europace; 2009 Sep; 11(9):1177-82. PubMed ID: 19661114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term prognosis after cardiac resynchronization therapy is related to the extent of left ventricular reverse remodeling at midterm follow-up.
    Ypenburg C; van Bommel RJ; Borleffs CJ; Bleeker GB; Boersma E; Schalij MJ; Bax JJ
    J Am Coll Cardiol; 2009 Feb; 53(6):483-90. PubMed ID: 19195605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between New York Heart Association class change and ventricular tachyarrhythmia occurrence in patients treated with cardiac resynchronization plus defibrillator.
    Lepillier A; Piot O; Gerritse B; Copie X; Lavergne T; Paziaud O; Lascault G; Waintraub X; Otmani A; Le Heuzey JY
    Europace; 2009 Jan; 11(1):80-5. PubMed ID: 18952828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of age and gender on cardiac resynchronization therapy outcome.
    Zardkoohi O; Nandigam V; Murray L; Heist EK; Mela T; Orencole M; Ruskin JN; Singh JP
    Pacing Clin Electrophysiol; 2007 Nov; 30(11):1344-8. PubMed ID: 17976097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Similar long-term benefits conferred by apical versus mid-septal implantation of the right ventricular lead in recipients of cardiac resynchronization therapy systems.
    Bulava A; Lukl J
    Pacing Clin Electrophysiol; 2009 Mar; 32 Suppl 1():S32-7. PubMed ID: 19250108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Six-minute walking test predicts long-term cardiac death in patients who received cardiac resynchronization therapy.
    Castel MA; Méndez F; Tamborero D; Mont L; Magnani S; Tolosana JM; Berruezo A; Godoy M; Sitges M; Vidal B; Roig E; Brugada J
    Europace; 2009 Mar; 11(3):338-42. PubMed ID: 19136491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiarrhythmic effect of reverse ventricular remodeling induced by cardiac resynchronization therapy: the InSync ICD (Implantable Cardioverter-Defibrillator) Italian Registry.
    Di Biase L; Gasparini M; Lunati M; Santini M; Landolina M; Boriani G; Curnis A; Bocchiardo M; Vincenti A; Denaro A; Valsecchi S; Natale A; Padeletti L;
    J Am Coll Cardiol; 2008 Oct; 52(18):1442-9. PubMed ID: 19017510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac resynchronization therapy in patients with mildly impaired left ventricular function.
    Foley PW; Stegemann B; Smith RE; Sanderson JE; Leyva F
    Pacing Clin Electrophysiol; 2009 Mar; 32 Suppl 1():S186-9. PubMed ID: 19250090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Remission of left ventricular systolic dysfunction and of heart failure symptoms after cardiac resynchronization therapy: temporal pattern and clinical predictors.
    Gasparini M; Regoli F; Ceriotti C; Galimberti P; Bragato R; De Vita S; Pini D; Andreuzzi B; Mangiavacchi M; Klersy C
    Am Heart J; 2008 Mar; 155(3):507-14. PubMed ID: 18294488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term performance of the attain model 4193 left ventricular lead.
    Johnson WB; Abraham WT; Young JB; Wheelan K; Smith AL; Chang Y; Brinkman P;
    Pacing Clin Electrophysiol; 2009 Sep; 32(9):1111-6. PubMed ID: 19719485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term effect of cardiac resynchronization therapy on functional mitral valve regurgitation.
    Sitges M; Vidal B; Delgado V; Mont L; Garcia-Alvarez A; Tolosana JM; Castel A; Berruezo A; Azqueta M; Pare C; Brugada J
    Am J Cardiol; 2009 Aug; 104(3):383-8. PubMed ID: 19616672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of reverse anatomical remodeling and ventricular arrhythmias after cardiac resynchronization.
    Markowitz SM; Lewen JM; Wiggenhorn CJ; Abraham WT; Stein KM; Iwai S; Lerman BB
    J Cardiovasc Electrophysiol; 2009 Mar; 20(3):293-8. PubMed ID: 19175852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of LOw-dose DObutamine stress-echocardiography to predict cardiac resynchronization therapy response (LODO-CRT) multicenter prospective study: design and rationale.
    Muto C; Gasparini M; Iacopino S; Peraldo C; Curnis A; Sassone B; Diotallevi P; Davinelli M; Valsecchi S; Tuccillo B
    Am Heart J; 2008 Oct; 156(4):656-61. PubMed ID: 18926147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of mortality and hospitalization for cardiac causes in patients with heart failure and nonischemic heart disease: a subanalysis of the ALPHA study.
    Anselmino M; De Ferrari GM; Massa R; Manca L; Tritto M; Molon G; Curnis A; Devecchi P; Sarzi Braga S; Bartesaghi G; Klersy C; Accardi F; Salerno-Uriarte JA;
    Pacing Clin Electrophysiol; 2009 Mar; 32 Suppl 1():S214-8. PubMed ID: 19250099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of 'super-responders' to cardiac resynchronization therapy: the importance of symptom duration and left ventricular geometry.
    António N; Teixeira R; Coelho L; Lourenço C; Monteiro P; Ventura M; Cristóvão J; Elvas L; Gonçalves L; Providência LA
    Europace; 2009 Mar; 11(3):343-9. PubMed ID: 19240109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.